REC - Recordati Industria Chimica e Farmaceutica S.p.A.
MIL
->
Healthcare
->
Drug Manufacturers—General
Milan,
Italy
Type: Equity
REC price evolution
REC
News
|
Recordati Net Revenue Climbs 12% in First 9 Months of 2024
Exec Edge · via Yahoo Finance
8 Nov 2024
|
|
Recordati Acquires Rights to Enjaymo from Sanofi for $825 Million
Exec Edge · via Yahoo Finance
8 Oct 2024
|
|
Sanofi’s rare disease drug finds yet another home
BioPharma Dive · via Yahoo Finance
1 Oct 2024
|
|
Recordati buys rights to rare immune disorder drug from Sanofi for $825 million
Reuters · via Yahoo Finance
1 Oct 2024
|
|
Sanofi Sells Global Rights To Rare Autoimmune Drug Enjaymo For $825M Upfront To...
Benzinga · via Yahoo Finance
1 Oct 2024
|
|
Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo
Pharmaceutical Technology · via Yahoo Finance
1 Oct 2024
|
|
21 Largest Italian Companies by Market Cap
Insider Monkey via Yahoo Finance
28 Jan 2023
|
|
Top 15 Most Valuable Italian Companies
Insider Monkey via Yahoo Finance
17 Jan 2022
|